// App-Quantinova.ai

TPS11132 : DETECT III/IV: Two combined clinical trials based on the phenotype of circulating tumor cells (CTCs).

Researchers

Presenter

  • Susanne Albrecht

Principal Investigators

  • Fabienne Schochter

  • Bernadette Jaeger

  • Brigitte Kathrin Rack

  • Volkmar Mueller

  • Peter A. Fasching

  • Wolfgang Janni

  • Tanja N. Fehm

Medical Centers

  • Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • Department of Gynecology and Obstetrics, Heinrich Heine University, Duesseldorf, GermanyDepartment of Gynecology and Obstetrics, Universitaetsklinikum Ulm, Ulm, GermanyDepartment of Obstetrics and Gynecology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany

  • Department of Gynecology and Obstetrics, University of Duesseldorf, Germany, Dueesseldorf, Germany

  • Department of Gynecology and Obstetrics Ludwig-MaximiliansUniversity, Munich, Germany

  • Universitatsklinikum Ulm, Ulm, Germany

  • Department of Gynecology and Obstetrics University Ulm, Ulm, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Lapatinib

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT02035813

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved